SAL-0951

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SAL-0951, covering 2024-08-13 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies [Phase 2]